Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $300.30 +1.55%
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
SFNC, CSBR, MAN, More
Revenue Growth %: -4.3%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
SFNC, CSBR, MAN, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.09, $0.14 better than the analyst estimate of $0.95. Revenue for the quarter came in at $536.8 million versus the consensus estimate of $537.58 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verizon to cut 3,000 jobs as it shifts stores to franchises
- Abbott beats second-quarter estimates, raises 2026 guidance
- Bank7 Corp. (BSVN) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
